tiprankstipranks
Trending News
More News >
ERYTECH PHARMA (FR:PHXM)
:PHXM
France Market

ERYTECH PHARMA (PHXM) Technical Analysis

Compare
2 Followers

Summary of all the Indicators

Overall Consensus
Strong Sell
3Bullish
5Neutral
14Bearish
Technical Analysis Consensus
Sell
2Bullish
5Neutral
3Bearish
Moving Average Consensus
Strong Sell
1Bullish
0Neutral
11Bearish
ERYTECH PHARMA’s (PHXM) Moving Averages Convergence Divergence (MACD) indicator is -0.15, suggesting ERYTECH PHARMA is a Sell.
ERYTECH PHARMA’s (PHXM) 20-Day exponential moving average is 0.53, while ERYTECH PHARMA’s (PHXM) share price is €0.38, making it a Sell.
ERYTECH PHARMA’s (PHXM) 50-Day exponential moving average is 0.86, while ERYTECH PHARMA’s (PHXM) share price is €0.38, making it a Sell.

ERYTECH PHARMA (PHXM) Pivot Points

May 12, 2025, 03:38 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.33
0.35
0.36
0.38
0.39
0.41
0.42
Fibonacci
0.35
0.36
0.37
0.38
0.39
0.40
0.41
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

ERYTECH PHARMA (PHXM) Moving Averages

May 12, 2025, 03:38 AM
Period
Simple
Exponential
MA5
0.37Buy
0.39Sell
MA10
0.40Sell
0.43Sell
MA20
0.53Sell
0.53Sell
MA50
0.97Sell
0.86Sell
MA100
1.37Sell
1.19Sell
MA200
1.56Sell
1.51Sell
ERYTECH PHARMA’s (PHXM) 10-Day exponential moving average is 0.43, while ERYTECH PHARMA’s (PHXM) share price is €0.38, making it a Sell.
ERYTECH PHARMA’s (PHXM) 100-Day exponential moving average is 1.19, while ERYTECH PHARMA’s (PHXM) share price is €0.38, making it a Sell.
ERYTECH PHARMA’s (PHXM) stock price is €0.38 and ERYTECH PHARMA’s (PHXM) 50-day simple moving average is 0.97, creating a Sell signal.
ERYTECH PHARMA’s (PHXM) stock price is €0.38 and ERYTECH PHARMA’s (PHXM) 100-day simple moving average is 1.37, creating a Sell signal.
ERYTECH PHARMA’s (PHXM) stock price is €0.38 and ERYTECH PHARMA’s (PHXM) 200-day simple moving average is 1.56, creating a Sell signal.

ERYTECH PHARMA (PHXM) Technical Indicators

May 12, 2025, 03:38 AM
Name
Value
Implied Action
RSI (14)
40.13
Neutral
STOCH (9,6)
53.49
Neutral
STOCHRSI (14)
38.83
Neutral
MACD (12,26)
-0.15
Sell
ADX (14)
12.62
Buy
Williams %R
-59.73
Buy
CCI (14)
-66.61
Neutral
ATR (14)
0.12
-
Ultimate Oscillator
41.00
Neutral
ROC
-43.91
Sell
ERYTECH PHARMA’s (PHXM) Relative Strength Index (RSI) is 40.13, creating a Neutral signal.
ERYTECH PHARMA’s (PHXM) Trend Strength Indicator (ADX) is 12.62, creating a Buy signal.
ERYTECH PHARMA’s (PHXM) Commodity Channel Index (CCI) is -66.61, creating a Neutral signal.
ERYTECH PHARMA’s (PHXM) Price Rate of Change (ROC) is -43.91, creating a Sell signal.

FAQ

Is PHXM a Buy, Hold, or Sell?
Based on PHXM’s technical indicators, PHXM is a Strong Sell.
    What is PHXM’s RSI (14)?
    PHXM’s RSI (14) is 40.13, which suggests PHXM is a Neutral.
      What is PHXM’s MACD?
      PHXM’s MACD is -0.15, which suggests PHXM is a Sell.
        What is PHXM’s 5-day moving average?
        PHXM’s 5-day moving average is 0.37, which suggests PHXM is a Buy.
          What is PHXM’s 20-day moving average?
          PHXM 20-day moving average is 0.53, which suggests PHXM is a Sell.
            What is PHXM’s 50-day moving average?
            PHXM’s 50-day moving average is 0.97, which suggests PHXM is a Sell.
              What is PHXM’s 200-day moving average?
              PHXM’s 200-day moving average is 1.56, which suggests PHXM is a Sell.
                What is PHXM’s Williams % R (14)?
                PHXM’s Williams % R (14) is -59.73, which suggests PHXM is a Buy.
                  What is PHXM’s CCI (14)?
                  PHXM’s CCI (14) is -66.61, which suggests PHXM is a Neutral.
                    What is the share price of ERYTECH PHARMA?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis